Literature DB >> 28919060

SGLT2 inhibitors in type 1 diabetes: knocked down, but up again?

John R Petrie1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28919060     DOI: 10.1016/S2213-8587(17)30315-7

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  3 in total

1.  Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes.

Authors:  Bruce A Perkins; Julio Rosenstock; Jay S Skyler; Lori M Laffel; David Z Cherney; Chantal Mathieu; Christianne Pang; Richard Wood; Ona Kinduryte; Jyothis T George; Jan Marquard; Nima Soleymanlou
Journal:  Diabetes Care       Date:  2019-06-08       Impact factor: 19.112

Review 2.  Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians.

Authors:  Ahmed Iqbal; Peter Novodvorsky; Simon R Heller
Journal:  Diabetes Metab J       Date:  2018-02       Impact factor: 5.376

3.  SGLT2 inhibitors and renal complications in type 1 diabetes.

Authors:  John R Petrie
Journal:  Lancet Diabetes Endocrinol       Date:  2020-10       Impact factor: 32.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.